24 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250610649423/en/shibio-Doses-First-Patient-in-Phase-1b-Trial-of-Andecaliximab-in-Patients-with-Spinal-Cord-Injury-SCI-at-Risk-of-Heterotopic-Ossification-HO
23 Jan 2025
// BUSINESSWIRE